Head and Neck Cancer News & Features
Patients with oropharyngeal cancer who were found to have detectable traces of human papillomavirus type 16 (HPV16) in their saliva.
A new proof of principle study seems to validate the usefulness of DNA testing to detect cancers in the oral cavity.
Study shows potential for noninvasive tumor detection for head and neck cancer.
The Medicare costs for older patients with oral cavity and pharyngeal cancers have increased due to several factors, including on demographics, treatment selection, and co-existing illnesses.
Certain human papillomavirus (HPV)-16 antibodies in the blood associated with improved survival in HPV-related oropharyngeal carcinoma.
Head and Neck Cancer Clinical Trials
- Unraveling of molecular changes in acute lymphoblastic leukemia (ALL) opens new treatment options
- Religiousness and spirituality have a significant impact on cancer patients' overall health and outcomes
- Breakthrough supportive care: Overcoming cancer anorexia/cachexia
- Adding regional nodal irradiation to whole-breast irradiation reduces breast cancer recurrence
- Even light drinking puts women at greater risk to develop cancer
- Researchers identify tumor microenvironment of metastasis (TMEM) that allows breast cancer to metastasize
- Race and institutional factors play important roles in pharmacogenomics trial participation
- Research group looking to bring Cuba's lung cancer vaccine to the United States
- Patients with advanced cancer prefer open, effective communication
- 26 percent of senior oncology patients use alternative therapies
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|